CD2AP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.109400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.942200E-01
Normal-vs-Stage2
5.359800E-01
Normal-vs-Stage3
5.771200E-01
Normal-vs-Stage4
3.972400E-01
Stage1-vs-Stage2
6.538200E-01
Stage1-vs-Stage3
3.804200E-01
Stage1-vs-Stage4
3.625200E-01
Stage2-vs-Stage3
1.410630E-01
Stage2-vs-Stage4
2.526600E-01
Stage3-vs-Stage4
1.989560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.404000E-01
Normal-vs-AfricanAmerican
6.355800E-01
Normal-vs-Asian
5.350200E-01
Caucasian-vs-AfricanAmerican
9.164400E-01
Caucasian-vs-Asian
7.573600E-01
AfricanAmerican-vs-Asian
9.128800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.684800E-01
Normal-vs-Female
6.678200E-01
Male-vs-Female
5.140600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.842400E-01
Normal-vs-Age(41-60Yrs)
3.982400E-01
Normal-vs-Age(61-80Yrs)
7.378000E-01
Normal-vs-Age(81-100Yrs)
6.002600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.543400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.062000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.876000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.953600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.799400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.617600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.701200E-01
Normal-vs-Daily Drinker
9.700600E-01
Normal-vs-Weekly Drinker
8.305600E-01
Normal-vs-Occasional Drinker
3.036200E-01
Normal-vs-Social Drinker
8.276200E-01
Non Drinker-vs-Daily Drinker
3.345200E-01
Non Drinker-vs-Weekly Drinker
6.232800E-01
Non Drinker-vs-Occasional Drinker
1.267200E-01
Non Drinker-vs-Social Drinker
4.679200E-01
Daily Drinker-vs-Weekly Drinker
7.548800E-01
Daily Drinker-vs-Occasional Drinker
5.240000E-02
Daily Drinker-vs-Social Drinker
8.136200E-01
Weekly Drinker-vs-Occasional Drinker
1.425580E-01
Weekly Drinker-vs-Social Drinker
9.068000E-01
Occasional Drinker-vs-Social Drinker
7.403600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.160040E-01
Normal-vs-Grade 2
1.776360E-02
Normal-vs-Grade 3
8.497800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.640080E-02
Grade 1-vs-Grade 3
4.862800E-03
Grade 1-vs-Grade 4
1.160040E-01
Grade 2-vs-Grade 3
3.880200E-01
Grade 2-vs-Grade 4
1.776360E-02
Grade 3-vs-Grade 4
8.497800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.954600E-01
Normal-vs-NonDiabetic
6.087400E-01
Diabetic-vs-NonDiabetic
4.536200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.494800E-01
Normal-vs-NoPancreatitis
6.474600E-01
Pancreatitis-vs-NoPancreatitis
5.610200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.578400E-01
Normal-vs-N1
5.705200E-01
N0-vs-N1
5.725200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.520040E-01
Normal-vs-TP53-NonMutant
6.772200E-01
TP53-Mutant-vs-TP53-NonMutant
1.588830E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
